Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Diabetes
Under what circumstances would you use pasireotide in the management of insulinoma-associated hypoglycemia?
Vega-Beyhart, et al., PMID 40165498
Related Questions
In patients using a tandem insulin pump on auto-mode/Control-IQ, would decreasing the basal settings on the profile actually reduce the delivered hourly insulin dose or is that only relevant if they switch to manual mode?
How do you approach adjusting insulin pump settings in patients who have received intra-articular corticosteroid injections?
Is the accuracy of continuous glucose monitors (DEXCOM or Libre) lower in patients undergoing dialysis?
How do you counsel patients on the use of berberine to prevent the progression of prediabetes to type 2 diabetes mellitus?
Is the combination of SGLT2i and GLP 1 R agonist therapy contraindicated in patients who develop an episode of euglycemic DKA?
How do you recommend adjusting insulin pump settings when transitioning from U-100 to U-200 Humalog insulin?
What is the recommended approach to treating severe constipation in patients on GLP1 R agonist therapy?
How do you titrate the dose of an ACE inhibitor in a patient with type 1 diabetes mellitus who is normotensive but has moderately increased albuminuria?
Is it safe to use acarbose in patients with advanced chronic kidney disease?
What patients with new onset diabetes require imaging of the pancreas?
